| Dr Harjinder S Grewal, MD | |
|
540 S Governors Ave Ste 201, Dover, DE 19904-3530 | |
| (302) 672-4600 | |
| (302) 672-4606 |
| Full Name | Dr Harjinder S Grewal |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 53 Years |
| Location | 540 S Governors Ave Ste 201, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699742585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | C10004533 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bayhealth Medical Center, Inc | 1658364740 | 288 |
News Archive
Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
"Pakistani health officials Monday called for infants leaving the country to be issued polio vaccinations at airports after virus samples linked to a southern Pakistani city were discovered in Egypt,"
Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
› Verified 6 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467546135 PECOS PAC ID: 1658364740 Enrollment ID: O20040405001600 |
News Archive
Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
"Pakistani health officials Monday called for infants leaving the country to be issued polio vaccinations at airports after virus samples linked to a southern Pakistani city were discovered in Egypt,"
Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
› Verified 6 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1285809509 PECOS PAC ID: 1658364740 Enrollment ID: O20081010000398 |
News Archive
Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
"Pakistani health officials Monday called for infants leaving the country to be issued polio vaccinations at airports after virus samples linked to a southern Pakistani city were discovered in Egypt,"
Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
› Verified 6 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1417473935 PECOS PAC ID: 1658364740 Enrollment ID: O20190429001388 |
News Archive
Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
"Pakistani health officials Monday called for infants leaving the country to be issued polio vaccinations at airports after virus samples linked to a southern Pakistani city were discovered in Egypt,"
Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
› Verified 6 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1063938439 PECOS PAC ID: 1658364740 Enrollment ID: O20190501000077 |
News Archive
Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
"Pakistani health officials Monday called for infants leaving the country to be issued polio vaccinations at airports after virus samples linked to a southern Pakistani city were discovered in Egypt,"
Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harjinder S Grewal, MD 640 S State St, Mail Code 3055, Dover, DE 19901-3530 Ph: (302) 480-1688 | Dr Harjinder S Grewal, MD 540 S Governors Ave Ste 201, Dover, DE 19904-3530 Ph: (302) 672-4600 |
News Archive
Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
"Pakistani health officials Monday called for infants leaving the country to be issued polio vaccinations at airports after virus samples linked to a southern Pakistani city were discovered in Egypt,"
Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], in Berlin today (Monday September 21). The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
› Verified 6 days ago
Theodore Conrad Ang Tan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 810 New Burton Rd, Suite 3, Dover, DE 19904 Phone: 302-730-0554 Fax: 302-730-1175 | |
Francis Lim, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 419-276-1194 | |
Safwan Muhammad, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 879-022-5410 | |
Dr. Wai Wai Lin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1058 S Governors Ave Ste 101, Dover, DE 19904 Phone: 302-401-1500 Fax: 302-672-6450 | |
Abdul Muhaymin Siyal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 720 S Queen St, Dover, DE 19904 Phone: 302-734-7834 Fax: 302-734-7847 | |
Dr. Daniel L. Fisher, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 333 Red Tail Dr, Dover, DE 19904 Phone: 302-943-8040 | |
Dr. Manmeet Brar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1198 S Governors Ave Ste B100, Dover, DE 19904 Phone: 302-734-3227 Fax: 302-734-0391 |